Treatment outcomes of patients with advanced gastrointestinal stromal tumors treated with imatinib m

来源 :22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) | 被引量 : 0次 | 上传用户:gaoHolly
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective: Imatinib mesylate, a selective tyrosine kinase inhibitor of KIT and platelet-derived growth factor receptor-α,is the first-line treatment for inoperable or metastatic gastrointestinal stromal tumors (GIST).The tolerability and long-term outcomes of imatinib treatment on patients with advanced GIST have rarely been reported, hence, the limited data.ibis study aimed to address the limited availability of data.Methods: A retrospective analysis was conducted on patients treated at UKMMC, UMMC, and HKL from January 2002to December 2012.A total of 107 patients who met the predetermined criteria were included in the study.Relevant data on the patient, disease, and treatment were obtained from patient medical records.The data were analyzed for response,progression-free survival, and overall survival.
其他文献
Objective: To evaluate the effect of breathing motions in chest wall intensity-modulated radiotherapy after radical mastectomy.The necessitty methods, and potential clinical value of accurately determ
会议
Objective: To determine whether EGFR can be used to predict prognosis to concurrent chemoradiotherapy (CCRT) of patients with locally advanced ESCC.Methods: A total of 47 patients with locally advance
会议
Objective: To analyze the prognostic factors in esophageal carcinoma patients after esophagectomy with stump carcinoma and atypical hyperplasia and to provide reasonable basis for prognosis evaluation
会议
Objective: To detect potential pathogenesis of neurogenesis impairment by investigating whether radiation inhibits BDNFTrkb signaling in the hippocampus via histone acetylation repression.
会议
Objective: To investigate the clinical characteristics and outcomes of patients with primary malignant mediastinal nonseminomatous germ cell tumor (MMNSGCT) by comparing the efficacies of different tr
会议
Objective: To assess the influence of P-glycoprotein (Pgp)inhibition (single-dose rifampin) and simultaneous CYP3A4and Pgp induction (multiple-dose rifampin) on lenvatinibpharmacokinetic parameters in
会议
Objectives: To investigate cetuximab added to concurrent chemoradiotherapy for Chinese patients with locally advanced esophageal squamous cell carcinoma (ESCC).Methods: Eligible patients with non-rese
会议
Objective: Carcinoid is categorized under neuroendocrine tumors, which occur rarely and produce various hormones.This study aims to investigate the clinical features, treatment options,and prognosis o
会议
Objective: To investigate the function of tetraspanin CD151 in the invasion and metastasis of hepatocellular carcinoma (HCC),and to explore the underlying mechanism.Methods: We detected the expression
会议
Objective: To evaluate the efficacy and safety of a two-week course of radiotherapy with oral capecitabine in patients with locally advanced rectal cancer.Methods: Eighty patients with mid to low rect
会议